Shudong Wang, Bo Yue, Tiyao Liu, Wenhao Wu, Wenjing Yin, Shanchen Pang
{"title":"A Multitask Prediction Framework for CircRNAs, Drugs, and Diseases Based on Multi-View Information Integration and Graph Contrastive Learning","authors":"Shudong Wang, Bo Yue, Tiyao Liu, Wenhao Wu, Wenjing Yin, Shanchen Pang","doi":"10.1021/acssynbio.6c00184","DOIUrl":null,"url":null,"abstract":"<p>As\r\na part of drug discovery, the exploration of circRNA-drug sensitivity\r\nassociations (CRAs), drug-disease associations (RDAs) has been an\r\nimportant means of understanding disease mechanisms and proposing\r\nnew treatment strategies. Due to the time-consuming and labor-intensive\r\nnature of biological experiments, computational methods have become\r\neffective solutions to this problem. However, existing computational\r\nmethods for inferring CRAs, RDAs typically operate in isolation, failing\r\nto exploit the rich interplay across circRNAs, drugs, and diseases.\r\nIn this paper, we propose MVII-GCL, a novel multitask prediction framework\r\nbuilt upon multiview information integration and graph contrastive\r\nlearning. MVII-GCL first constructs a multiview network encompassing\r\nattribute, topology, and association perspectives, explicitly tailored\r\nto capture the unique characteristics of each domain. To map multiview\r\ninformation into a unified latent space, our multiview attention encoder\r\nmodule employs domain-specific encoders to learn specialized representations,\r\nfollowed by a Top-k sparse attention mechanism. To further bolster\r\nrobustness against data sparsity and noise, a symmetric graph contrastive\r\nlearning objective is seamlessly integrated as a regularization term\r\nwithin the multitask learning paradigm. 5-fold cross-validation demonstrates\r\nour model’s strong performance, achieving AUC, AUPR, and <em>F</em>1 scores of 0.9764, 0.9750, and 0.9234 in drug-disease\r\nassociation prediction, and 0.9301, 0.9339, and 0.8609 in circRNA-drug\r\nsensitivity prediction.Furthermore, case studies further support the\r\nmodel’s ability to discover potential associations.</p>","PeriodicalId":26,"journal":{"name":"ACS Synthetic Biology","volume":"15 8","pages":"3310–3321"},"PeriodicalIF":4.5000,"publicationDate":"2026-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Synthetic Biology","FirstCategoryId":"99","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acssynbio.6c00184","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/7/1 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0
Abstract
As
a part of drug discovery, the exploration of circRNA-drug sensitivity
associations (CRAs), drug-disease associations (RDAs) has been an
important means of understanding disease mechanisms and proposing
new treatment strategies. Due to the time-consuming and labor-intensive
nature of biological experiments, computational methods have become
effective solutions to this problem. However, existing computational
methods for inferring CRAs, RDAs typically operate in isolation, failing
to exploit the rich interplay across circRNAs, drugs, and diseases.
In this paper, we propose MVII-GCL, a novel multitask prediction framework
built upon multiview information integration and graph contrastive
learning. MVII-GCL first constructs a multiview network encompassing
attribute, topology, and association perspectives, explicitly tailored
to capture the unique characteristics of each domain. To map multiview
information into a unified latent space, our multiview attention encoder
module employs domain-specific encoders to learn specialized representations,
followed by a Top-k sparse attention mechanism. To further bolster
robustness against data sparsity and noise, a symmetric graph contrastive
learning objective is seamlessly integrated as a regularization term
within the multitask learning paradigm. 5-fold cross-validation demonstrates
our model’s strong performance, achieving AUC, AUPR, and F1 scores of 0.9764, 0.9750, and 0.9234 in drug-disease
association prediction, and 0.9301, 0.9339, and 0.8609 in circRNA-drug
sensitivity prediction.Furthermore, case studies further support the
model’s ability to discover potential associations.
期刊介绍:
The journal is particularly interested in studies on the design and synthesis of new genetic circuits and gene products; computational methods in the design of systems; and integrative applied approaches to understanding disease and metabolism.
Topics may include, but are not limited to:
Design and optimization of genetic systems
Genetic circuit design and their principles for their organization into programs
Computational methods to aid the design of genetic systems
Experimental methods to quantify genetic parts, circuits, and metabolic fluxes
Genetic parts libraries: their creation, analysis, and ontological representation
Protein engineering including computational design
Metabolic engineering and cellular manufacturing, including biomass conversion
Natural product access, engineering, and production
Creative and innovative applications of cellular programming
Medical applications, tissue engineering, and the programming of therapeutic cells
Minimal cell design and construction
Genomics and genome replacement strategies
Viral engineering
Automated and robotic assembly platforms for synthetic biology
DNA synthesis methodologies
Metagenomics and synthetic metagenomic analysis
Bioinformatics applied to gene discovery, chemoinformatics, and pathway construction
Gene optimization
Methods for genome-scale measurements of transcription and metabolomics
Systems biology and methods to integrate multiple data sources
in vitro and cell-free synthetic biology and molecular programming
Nucleic acid engineering.